Home
Conditions
Kidney Neoplasms

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies

Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

NCT00556049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center' Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

NCT00467025

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +14 more
Locations: Not specified

View Trial Details

Completed

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

NCT02714790

Conditions: Acute Myeloid Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

NCT01062178

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Toronto General Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

NCT02370290

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery

NCT00227760

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

London Regional Cancer Program London, Ontario, Canada

View Trial Details

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

NCT01014065

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations: University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Completed

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

NCT00334282

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: GSK Investigational Site Capital Federal, Buenos Aires, Argentina

GSK Investigational Site Córdoba, Córdoba Province, Argentina

GSK Investigational Site Rosario, Santa Fe Province, Argentina

GSK Investigational Site Quilmes, Argentina

View all 99 locations

View Trial Details

Completed

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

NCT01402089

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
Locations: Cantonal Hospital St.Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

NCT01169584

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Ewing's Sarcoma, +54 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Kidney Neoplasms

Kidney Neoplasms trial results

Related conditions